141 related articles for article (PubMed ID: 38609254)
1. Biosensing-based quality control monitoring of the higher-order structures of therapeutic antibody domains.
Watanabe H; Hayashida N; Sato M; Honda S
Anal Chim Acta; 2024 May; 1303():342439. PubMed ID: 38609254
[TBL] [Abstract][Full Text] [Related]
2. Biosensing Probe for Quality Control Monitoring of the Structural Integrity of Therapeutic Antibodies.
Watanabe H; Yageta S; Imamura H; Honda S
Anal Chem; 2016 Oct; 88(20):10095-10101. PubMed ID: 27700033
[TBL] [Abstract][Full Text] [Related]
3. Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.
Alfaleh MA; Alsaab HO; Mahmoud AB; Alkayyal AA; Jones ML; Mahler SM; Hashem AM
Front Immunol; 2020; 11():1986. PubMed ID: 32983137
[TBL] [Abstract][Full Text] [Related]
4. Phage display approaches for the isolation of monoclonal antibodies against dengue virus envelope domain III from human and mouse derived libraries.
Moreland NJ; Susanto P; Lim E; Tay MYF; Rajamanonmani R; Hanson BJ; Vasudevan SG
Int J Mol Sci; 2012; 13(3):2618-2635. PubMed ID: 22489114
[TBL] [Abstract][Full Text] [Related]
5. Applications of High-Throughput DNA Sequencing to Single-Domain Antibody Discovery and Engineering.
Lowden MJ; Lei EK; Hussack G; Henry KA
Methods Mol Biol; 2023; 2702():489-540. PubMed ID: 37679637
[TBL] [Abstract][Full Text] [Related]
6. Specific and selective probes for Pseudomonas aeruginosa from phage-displayed random peptide libraries.
Carnazza S; Foti C; Gioffrè G; Felici F; Guglielmino S
Biosens Bioelectron; 2008 Feb; 23(7):1137-44. PubMed ID: 18068970
[TBL] [Abstract][Full Text] [Related]
7. Selection of recombinant anti-SH3 domain antibodies by high-throughput phage display.
Huang H; Economopoulos NO; Liu BA; Uetrecht A; Gu J; Jarvik N; Nadeem V; Pawson T; Moffat J; Miersch S; Sidhu SS
Protein Sci; 2015 Nov; 24(11):1890-900. PubMed ID: 26332758
[TBL] [Abstract][Full Text] [Related]
8. Generation by phage display and characterization of drug-target complex-specific antibodies for pharmacokinetic analysis of biotherapeutics.
Harth S; Ten Haaf A; Loew C; Frisch C; Knappik A
MAbs; 2019 Jan; 11(1):178-190. PubMed ID: 30516449
[TBL] [Abstract][Full Text] [Related]
9. A High-Throughput Magnetic Nanoparticle-Based Semi-Automated Antibody Phage Display Biopanning.
Ch'ng ACW; Ahmad A; Konthur Z; Lim TS
Methods Mol Biol; 2019; 1904():377-400. PubMed ID: 30539481
[TBL] [Abstract][Full Text] [Related]
10. Advance in phage display technology for bioanalysis.
Tan Y; Tian T; Liu W; Zhu Z; J Yang C
Biotechnol J; 2016 Jun; 11(6):732-45. PubMed ID: 27061133
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of synthetic antibodies binding to the cystic fibrosis conductance regulator.
Gakhal AK; Jensen TJ; Bozoky Z; Roldan A; Lukacs GL; Forman-Kay J; Riordan JR; Sidhu SS
MAbs; 2016; 8(6):1167-76. PubMed ID: 27185291
[TBL] [Abstract][Full Text] [Related]
12. The role of phage display in therapeutic antibody discovery.
Chan CE; Lim AP; MacAry PA; Hanson BJ
Int Immunol; 2014 Dec; 26(12):649-57. PubMed ID: 25135889
[TBL] [Abstract][Full Text] [Related]
13. An improved selection procedure for the screening of phage display peptide libraries.
D'Mello F; Howard CR
J Immunol Methods; 2001 Jan; 247(1-2):191-203. PubMed ID: 11150550
[TBL] [Abstract][Full Text] [Related]
14. Single domain antibodies specific for HER2 dimerization domain effectively disrupts HER2 dimerization.
Najafi A; Valadan R; Asgarian-Omran H; Rafiei A; Tehrani M
Int Immunopharmacol; 2023 Nov; 124(Pt B):110999. PubMed ID: 37804659
[TBL] [Abstract][Full Text] [Related]
15. Array-in-well binding assay for multiparameter screening of phage displayed antibodies.
Pérez-Gamarra S; Hattara L; Batra G; Saviranta P; Lamminmäki U
Methods; 2017 Mar; 116():43-50. PubMed ID: 27956240
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical production: Applications of surface plasmon resonance biosensors.
Thillaivinayagalingam P; Gommeaux J; McLoughlin M; Collins D; Newcombe AR
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(2):149-53. PubMed ID: 19762290
[TBL] [Abstract][Full Text] [Related]
17. Cognizance of Molecular Methods for the Generation of Mutagenic Phage Display Antibody Libraries for Affinity Maturation.
Lim CC; Choong YS; Lim TS
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991723
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Antibody Selections by Combining Phage and Yeast Display.
Ferrara F; Soluri MF; Sblattero D
Methods Mol Biol; 2019; 1904():339-352. PubMed ID: 30539479
[TBL] [Abstract][Full Text] [Related]
19. Recombinant antibodies by phage display for bioanalytical applications.
Guliy OI; Evstigneeva SS; Dykman LA
Biosens Bioelectron; 2023 Feb; 222():114909. PubMed ID: 36462427
[TBL] [Abstract][Full Text] [Related]
20. Planning Implications Related to Sterilization-Sensitive Science Investigations Associated with Mars Sample Return (MSR).
Velbel MA; Cockell CS; Glavin DP; Marty B; Regberg AB; Smith AL; Tosca NJ; Wadhwa M; Kminek G; Meyer MA; Beaty DW; Carrier BL; Haltigin T; Hays LE; Agee CB; Busemann H; Cavalazzi B; Debaille V; Grady MM; Hauber E; Hutzler A; McCubbin FM; Pratt LM; Smith CL; Summons RE; Swindle TD; Tait KT; Udry A; Usui T; Westall F; Zorzano MP
Astrobiology; 2022 Jun; 22(S1):S112-S164. PubMed ID: 34904892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
